Janus Henderson Group
CRGX

Janus Henderson Group’s CARGO Therapeutics CRGX Stock Holding History

Janus Henderson Group’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,830,544
Closed -$40.9M – 2497
2024
Q4 		$40.9M Buy
2,830,544
+155,259
+6% +$2.82M 0.02% 419
2024
Q3 		$49.3M Buy
2,675,285
+46,659
+2% +$835K 0.03% 392
2024
Q2 		$43.1M Sell
2,628,626
-30,954
-1% -$589K 0.02% 412
2024
Q1 		$59.3M Sell
2,659,580
-43,151
-2% -$1.03M 0.03% 356
2023
Q4 		$62.6M Buy
+2,702,731
New +$45.8M 0.04% 335

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

Janus Henderson Group's CRGX Position: Q1 2025 in Review

Janus Henderson Group sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 2,830,544 shares — an estimated $40.9M sold.

Janus Henderson Group first reported a position in CRGX in Q4 2023 and held it in 5 quarters. The position peaked at $62.6M in Q4 2023. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • Janus Henderson Group reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 2,830,544 CARGO Therapeutics shares in Q1 2025, an estimated $40.9M.
  • Janus Henderson Group first reported a position in CARGO Therapeutics in Q4 2023 and held it in 5 quarters.
  • Janus Henderson Group's CARGO Therapeutics position peaked at $62.6M in Q4 2023.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.